Fulcrum Therapeutics Inc. (FULC) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts FULC Hot Sheet
Join SI Premium – FREE
Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q3 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Centuri reports $475M+ in new contract awards for 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
